Tech Center 1600 • Art Units: 1655 1657
This examiner grants 68% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18807444 | SYSTEMS AND METHODS FOR THROMBOSIS PREVENTION | Non-Final OA | P Tech, LLC |
| 17995072 | METHODS FOR TREATING INFLAMMATORY AND FIBROTIC DISEASES AND DISORDERS | Non-Final OA | YALE UNIVERSITY |
| 18697698 | COMPOSITION FOR TREATING ALZHEIMER'S DISEASE INCLUDING MIXED EXTRACT OF PINELLIA TUBER, ZIZYPHI FRUCTUS, GLYCYRRHIZA RADIX, GINSENG RADIX, ZINGIBERIS RHIZOMA, SCUTELLARIAE RADIX, AND COPTIDIS RHIZOMA AS ACTIVE INGREDIENT | Non-Final OA | DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 18448304 | Personal Care Compositions | Non-Final OA | Colgate-Palmolive Company |
| 18135795 | METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF GRAFT VERSUS HOST DISEASE | Non-Final OA | UNIVERSITY OF MIAMI |
| 18510941 | COMPOSITIONS FOR INHIBITING EHP INFECTION IN SHRIMP AND RELATED METHODS | Non-Final OA | KEMIN INDUSTRIES, INC. |
| 18651293 | BETA-ADRENERGIC AGONIST AND MUSCARINIC ANTAGONIST COMPOSITIONS AND METHODS OF USING | Non-Final OA | Bonafide Health, LLC |
| 18701070 | THERAPEUTIC AND PREVENTIVE COMPOSITIONS | Non-Final OA | Cellnutrition Ltd |
| 18569901 | COMPOSITIONS COMPRISING CURCUMINOIDS FOR USE IN THE TREATMENT OF MUSCLE SORENESS | Non-Final OA | Givaudan SA |
| 18033010 | IMPROVEMENTS IN OR RELATING TO EXTRACTS | Non-Final OA | Givaudan SA |
| 18619650 | HAIR GROWTH COMPOSITION AND METHODS THEREOF | Non-Final OA | Chelsea Ashira LLC |
| 18696920 | METHOD OF TREATING CANCER | Non-Final OA | Native Ingredients and Health Research Organisation Pty Ltd |
| 18615562 | NATURAL SKIN PENETRATING MOISTURIZER FORMULATIONS | Final Rejection | DVA INC. |
| 18611998 | COSMETIC COMPOSITIONS COMPRISING A CACTUS FLOWER EXTRACT COMPLEX | Non-Final OA | SKG Beauty Holdings, Inc |
| 18681081 | NUTRITIONAL COMPOSITION FOR MUSCLE MASS, STRENGTH AND FUNCTION | Non-Final OA | N.V. Nutricia |
| 18691629 | TOPICAL PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF INFERTILITY | Non-Final OA | CHEMEX GLOBAL |
| 18592767 | Dry Insecticide Mixtures, Distributors, and Methods of Distributing a Dry Insecticide | Non-Final OA | Jones-Hamilton Co. |
| 18293854 | ARTHROPOD CONTROL PRODUCTS | Non-Final OA | Firmenich SA |
| 18156364 | THERAPEUTIC HERBAL COMPOSITIONS FOR IMPROVING LIVER HEALTH | Non-Final OA | KARALLIEF, INC. |
| 18577877 | COMPOSITION FOR IMPROVING UNIDENTIFIED COMPLAINTS, DEPRESSION, IMPAIRED CONCENTRATION, DECREASED MOTIVATION FOR SOCIALIZATION AND DAILY ACTIVITIES, AUTONOMIC NERVOUS SYSTEM DISORDERS, PAIN, CONTROL AND POOR SLEEP QUALITY ASSOCIATED WITH MENSTRUATION. | Non-Final OA | Tokiwa Phytochemical Co., Ltd. |
| 18543830 | TURMERIC OIL ESSENTIAL-OIL BISABOLENE SESQUITERPENOIDS IN THE TREATMENT OF NON-NEURODEGENERATIVE DISEASES | Non-Final OA | UNIVERSIDAD DE CUENCA |
| 18538894 | EXTRACTION OF COMPOUNDS WITH BETA-CARYOPHYLLENE, COMPOSITIONS AND USES THEREOF | Non-Final OA | Synaptix Inc. |
| 18534272 | EDIBLE CANNABIS PLANT POWDER | Non-Final OA | The Hemp Tea Company, LLC |
| 18526617 | Method for the treatment of microbial overgrowth, imbalance and infections | Non-Final OA | TRINUTRA LTD. |
| 18511853 | EQUINE-SPECIFIC THERAPEUTIC COMPOSITIONS AND METHODS OF USE | Non-Final OA | EquiStem Technology, LLC dba Equus Innovations |
| 18510162 | COMPOSITIONS FOR MITIGATING THE EFFECTS OF ALCOHOL CONSUMPTION AND METHODS RELATED THERETO | Non-Final OA | LIFTED BEVERAGES CORPORATION |
| 18264918 | THERAPEUTIC COMPOSITION BASED ON DHODH-INHIBITING NEUROLAENA LEAVES FOR THE TREATMENT OF RNA VIRUS INFECTIONS | Non-Final OA | PHYTOBOKAZ |
| 18275798 | BERTHOLLETIA EXCELSA EXTRACT AND USE THEREOF | Non-Final OA | BERACA INGREDIENTES NATURAIS LTDA. |
| 18350891 | Enhanced Mediterranean Diet-Based Nutritional Compositions And Methods | Non-Final OA | DailyColors Health Inc. |
| 18128858 | TISSUE REPAIR AND WOUND HEALING COMPOSITION AND METHOD USING LOW MOLECULAR WEIGHT HYDROLYZED COLLAGEN | Non-Final OA | SANARA MEDTECH APPLIED TECHNOLOGIES, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy